79 related articles for article (PubMed ID: 6228459)
1. Immunogenicity and safety of heat-inactivated hepatitis B vaccine (CLB) in low risk human volunteers and in patients treated with chronic haemodialysis in the Netherlands.
Reerink-Brongers EE; Lelie PN; Reesink HW; Dees PJ; Brummelhuis HG; van Aken WG
Dev Biol Stand; 1983; 54():197-203. PubMed ID: 6228459
[TBL] [Abstract][Full Text] [Related]
2. Efficacy trial of heat-inactivated hepatitis B vaccine (CLB) in male homosexuals in the Netherlands.
Coutinho RA; Lelie PN; Albrecht-van Lent P; Stoutjesdijk L; Huisman J; Kuipers H; Schut LJ; Reerink-Brongers EE; Reesink HW; van Aken WG
Dev Biol Stand; 1983; 54():287-92. PubMed ID: 6228469
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B vaccine: clinical trials in high-risk settings in France. (September 1975-September 1982).
Goudeau A; Dubois F; Barin F; Dubois MC; Coursaget P
Dev Biol Stand; 1983; 54():267-84. PubMed ID: 6228468
[TBL] [Abstract][Full Text] [Related]
4. Immune response to a heat-inactivated hepatitis B vaccine in patients undergoing hemodialysis. Enhancement of the response by increasing the dose of hepatitis B surface antigen from 3 to 27 micrograms.
Lelie PN; Reesink HW; de Jong-van Manen ST; Dees PJ; Reerink-Brongers EE
Arch Intern Med; 1985 Feb; 145(2):305-9. PubMed ID: 3977491
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B vaccine: safety study in anti-HBs seronegative human volunteers.
Kaufmann R; Mondorf AW; Uthemann H; Bauer H; Prince AM
Dev Biol Stand; 1983; 54():229-35. PubMed ID: 6228463
[TBL] [Abstract][Full Text] [Related]
6. Active hepatitis B immunization with an experimental German vaccine. I. Immunogenicity studies in healthy adults. II. The primary 19 S and 7 S responses to HBsAg in healthy adults. III. Immunogenicity studies in hemodialysis patients.
Scheiermann N; Kuwert EK
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):439-55. PubMed ID: 6485639
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B vaccine: safety study in anti-HBs seropositive human volunteers.
Kaufmann R; Mondorf AW; Uthemann H; Bauer H; Prince AM
Dev Biol Stand; 1983; 54():223-7. PubMed ID: 6228462
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B in haemodialysis: vaccination against HBS antigen.
Crosnier J
Proc Eur Dial Transplant Assoc; 1981; 18():231-40. PubMed ID: 7036150
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy and tolerance of hepatitis B vaccination in medical personnel and hemodialysis patients].
Horak W; Leithner C; Kemenesi W; Pinggera W
Wien Klin Wochenschr; 1984 Feb; 96(4):161-5. PubMed ID: 6231779
[TBL] [Abstract][Full Text] [Related]
11. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
[TBL] [Abstract][Full Text] [Related]
12. Low-dose intradermal and subcutaneous versus intramuscular hepatitis B vaccination in primary non-responding hemodialysis patients.
Sorkhi H; Dooki MR; Ebrahimnejad MS
J Med Assoc Thai; 2006 Oct; 89(10):1648-53. PubMed ID: 17128839
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B vaccine in developing countries: problems and prospects.
Ayoola EA
IARC Sci Publ; 1984; (63):297-305. PubMed ID: 6242148
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and long-term immunogenicity of hepatitis B vaccine in haemodialysis patients.
Ramezani A; Eslamifar A; Banifazl M; Ahmadi F; Maziar S; Razeghi E; Kalantar E; Amirkhani A; Aghakhani A
Int J Clin Pract; 2009 Mar; 63(3):394-7. PubMed ID: 18005039
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of hepatitis B virus vaccine (Heptavax-B)--response of healthy adults.
Beasley RP; Hwang LY
West J Med; 1984 May; 140(5):731-4. PubMed ID: 6233795
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B vaccine: simultaneous passive and active immunization. Indications in pre- and post-exposure.
Goudeau A; Dubois F; Geslin N; Pierre D
Dev Biol Stand; 1983; 54():259-66. PubMed ID: 6228467
[TBL] [Abstract][Full Text] [Related]
17. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
18. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal).
Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P
IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150
[TBL] [Abstract][Full Text] [Related]
19. Preliminary results of immune response to hepatitis B (HB) vaccine (Pasteur) in adults.
Giunchi G; Panichi G; Pescini A; Pezzella M; Galli C; Chircu LV; Sorice F
Dev Biol Stand; 1983; 54():153-9. PubMed ID: 6228454
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]